Cellseed Inc. | Income Statement

Fiscal year is January-December. All values JPY Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
105,769.00
86,325.00
193,118.00
100,673.00
85,061.00
Cost of Goods Sold (COGS) incl. D&A
53,426.00
48,948.00
43,218.00
19,855.00
34,040.00
Gross Income
52,343.00
37,377.00
149,900.00
80,818.00
51,021.00
SG&A Expense
586,793.00
639,326.00
717,966.00
1,494,692.00
1,075,787.00
EBIT
534,450.00
601,949.00
568,066.00
1,413,874.00
1,024,766.00
Unusual Expense
-
8,097.00
-
1,305.00
-
Non Operating Income/Expense
47,561.00
28,828.00
35,834.00
3,255.00
60,568.00
Pretax Income
581,921.00
580,645.00
531,523.00
1,415,613.00
964,184.00
Income Tax
2,667.00
2,054.00
3,730.00
1,357.00
2,290.00
Consolidated Net Income
584,588.00
582,699.00
535,253.00
1,414,255.00
966,474.00
Net Income
584,588.00
582,699.00
535,253.00
1,414,255.00
966,474.00
Net Income After Extraordinaries
584,588.00
582,699.00
535,253.00
1,414,255.00
966,474.00
Net Income Available to Common
584,588.00
582,699.00
535,253.00
1,414,255.00
966,474.00
EPS (Basic)
81.75
67.50
61.56
154.95
93.30
Basic Shares Outstanding
7,150.00
8,633.00
8,695.00
9,127.00
10,359.00
EPS (Diluted)
81.76
67.50
61.56
154.95
93.30
Diluted Shares Outstanding
7,150.00
8,633.00
8,695.00
9,127.00
10,359.00
EBITDA
533,061.00
599,413.00
558,613.00
1,405,790.00
1,020,040.00
Non-Operating Interest Income
90.00
573.00
709.00
208.00
13.00

About Cellseed

View Profile
Address
Telecom Center Building, 15/F
Tokyo Tokyo 135
Japan
Employees -
Website http://www.cellseed.com
Updated 09/14/2018
CellSeed Inc. develops regenerative medicine products. Its operations are carried out through the following business divisions: Cell Sheet Regenerative Medicine and Intelligent Cell Culture Ware Products. The Cell Sheet Regenerative Medicine division provides research, development, marketing, and sale of epithelial cell sheet for corneal and esophageal regeneration; regenerated cardiac patch to treat heart diseases; cell sheet for periodontal tissue regeneration; and regenerated cartilage sheet for the treatment of osteoarthritis.